Clinical trial

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

NCT07271602

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Quad shot Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Immune Checkpoint Inhibitors Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-01-30

PhasePHASE2

Conditions

Non Small Cell Lung Cancerunresolved

Immunotherapyunresolved

Radiotherapyunresolved

Chemotherapyunresolved

Interventions

Quad shotRADIATION

ChemotherapyDRUG

Immune Checkpoint InhibitorsDRUG

Sponsors & collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07271602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.